Enabling technologies for the efficient and sustained delivery of peptides and proteins

Extend Biosciences Inc. is a clinical stage biotechnology company developing a novel drug delivery platform technology that improves the pharmacokinetic properties of peptides and proteins.

Peptides have been particularly challenging to bring to market because they are removed from circulation prior to administering therapeutic value.

Our proprietary D-VITylation® platform technology significantly improves the circulating half-life and bioavailability of peptides and proteins, enabling the development potent and specific drugs.